Biotricity 推出了 HeartSecure，这是一项直接面向患者的家庭心脏筛查服务，面向 1.27 亿有心脏病风险的美国人。 Biotricity launches HeartSecure, a direct-to-patient home-based cardiac screening service for 127M Americans at risk of heart disease.

Biotricity Inc. 宣布即将推出直接面向患者的项目 HeartSecure，为 1.27 亿有心脏病风险的美国人提供家庭心脏筛查服务。 Biotricity Inc. announces its upcoming direct-to-patient program, HeartSecure, offering a home-based cardiac screening service for 127M Americans at risk of heart disease. 这项开创性的举措旨在颠覆价值 10.5 亿美元的家庭心脏健康市场，为个人提供在家主动进行的心脏健康检查，减少心脏病专家筛查等待时间长达一个月的情况。 This groundbreaking initiative aims to disrupt the $1.05B Home Heart Health market, providing individuals with proactive heart health checks from home, alleviating the 1-month wait times for screenings with cardiologists.